Avricore Health (AVCRF) Short-term Investments (2014 - 2022)

Avricore Health (AVCRF) has 9 years of Short-term Investments data on file, last reported at $237691.3 in Q3 2022.

• Short-term Investments for Q3 2022 came in at $237691.3, down 3.48% year-over-year; the trailing twelve-month figure through Sep 2022 was $237691.3 (down 3.48% YoY), and the FY2021 annual result was $247366.2, up 3213.77% from the prior year.
• Short-term Investments slipped to $237691.3 in Q3 2022 per AVCRF's latest filing, from $243145.6 in the prior quarter.
• Over five years, Short-term Investments peaked at $252193.4 in Q2 2021 and troughed at $7212.0 in Q2 2020.
• A 5-year average of $110813.7 and a median of $12836.8 in 2018 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2020 and 2021: Short-term Investments tumbled 43.06% in 2020, then soared 3396.84% in 2021.
• A 5-year view of Short-term Investments shows it stood at $12840.1 in 2018, then decreased by 1.35% to $12667.0 in 2019, then sank by 39.44% to $7670.5 in 2020, then surged by 3106.21% to $245934.2 in 2021, then slipped by 3.35% to $237691.3 in 2022.
• Business Quant data shows AVCRF's Short-term Investments at $237691.3 in Q3 2022, $243145.6 in Q2 2022, and $244737.4 in Q1 2022.